The human genome is widely transcribed, containing protein-coding and non-coding regions. Double-stranded DNA is transcribed to sense transcripts that are eventually translated to form proteins. Some DNA is transcribed into natural antisense RNA (NAT), which are endogenous transcripts that are complementary to sense transcripts. NATs are widespread in eukaryotes with complementary to sense transcripts of diverse biological function, and are thought to play a role in antisense-mediated gene regulation. Functional NATs have recently been identified as being involved in human disorders such as Alzheimer's disease, Parkinson's disease, and Fragile X syndrome. It is thought that 50-70% of sense transcripts have antisense partners, and an accurate and thorough characterization of NATs is needed to understand their role in homeostasis and disease progression. Future utilization of NATs to modify the expression of their cognate sense genes is a promising technology for disease therapeutics.
